
Tatva Chintan Sees Revision in Market Assessment Amid Strong Financial and Technical Indicators
2025-11-28 10:05:12Tatva Chintan, a small-cap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting recent developments across multiple analytical parameters. This shift highlights evolving perspectives on the company’s financial health, valuation, technical trends, and overall quality within a competitive industry landscape.
Read More
Tatva Chintan Pharma Chem Hits New 52-Week High at Rs.1603.6
2025-11-18 10:09:08Tatva Chintan Pharma Chem, a key player in the Specialty Chemicals sector, reached a significant milestone today by hitting a new 52-week high of Rs.1603.6. This achievement marks a notable moment in the stock’s performance, reflecting sustained momentum amid a fluctuating market backdrop.
Read More
Tatva Chintan Pharma Chem Hits New 52-Week High at Rs.1603.6
2025-11-18 10:09:00Tatva Chintan Pharma Chem, a key player in the Specialty Chemicals sector, reached a significant milestone today by hitting a new 52-week high of Rs.1603.6. This achievement marks a notable moment in the stock’s performance, reflecting sustained momentum amid a mixed market backdrop.
Read More
Tatva Chintan Pharma Chem Hits New 52-Week High at Rs.1603.6
2025-11-18 10:08:58Tatva Chintan Pharma Chem, a key player in the Specialty Chemicals sector, reached a significant milestone today by hitting a new 52-week high of Rs.1603.6. This achievement underscores the stock's strong momentum amid a mixed market backdrop, reflecting its sustained performance over the past year.
Read More
Tatva Chintan Pharma Chem Hits Day High with Strong 7.08% Gain
2025-11-17 15:32:42Tatva Chintan Pharma Chem's stock has reached a new 52-week high, reflecting strong performance with consecutive gains over the past two days. The stock is trading above key moving averages and has significantly outperformed its sector and the broader market over the past month, indicating a robust position in the specialty chemicals industry.
Read More
Tatva Chintan Pharma Chem Hits New 52-Week High at Rs. 1599.2
2025-11-17 11:24:33Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong performance in the specialty chemicals sector. The stock has shown consecutive gains and remains above key moving averages, indicating a solid market position. Its one-year performance significantly surpasses that of the broader market indices.
Read More
Tatva Chintan Pharma Chem Hits New 52-Week High of Rs. 1599.2
2025-11-17 11:24:27Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong performance in the specialty chemicals sector. The stock has shown consecutive gains and remains above key moving averages, indicating resilience. Over the past year, it has significantly outperformed the broader market, highlighting its robust market position.
Read More
Tatva Chintan Pharma Chem Hits New 52-Week High of Rs. 1599.2
2025-11-17 11:24:26Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong performance in the specialty chemicals sector. The stock has shown consecutive gains and remains above key moving averages. Over the past year, it has significantly outperformed the Sensex, with notable net profit growth reported in its latest quarterly results.
Read More
Tatva Chintan Pharma Chem Hits New 52-Week High of Rs. 1599.2
2025-11-17 11:24:26Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong market momentum and a notable performance in the specialty chemicals sector. The company has outperformed its sector and reported significant growth in net profit, showcasing financial stability with a low debt-to-equity ratio.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22-Nov-2025 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15-Nov-2025 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Nov-2025 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Corporate Actions
No Upcoming Board Meetings
Tatva Chintan Pharma Chem Ltd has declared 10% dividend, ex-date: 12 Sep 25
No Splits history available
No Bonus history available
No Rights history available






